Neurogene (NGNE) Times Interest Earned (2013 - 2026)
Neurogene (NGNE) posted Times Interest Earned of -$4.63 for Q1 2026, up 99.98% on a QoQ basis from -$27529.0 in Q4 2025, and up 87.49% year-over-year from -$2.47 in Q1 2025.
Neurogene (NGNE) Times Interest Earned (2013 - 2026) Analysis & Trends
Neurogene's Times Interest Earned history runs 13 years deep, the most recent figure standing at -$4.63 for Q1 2026.
- Quarterly Times Interest Earned rose 87.49% year-over-year to -$4.63 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$15.38 (up 88.0% YoY) and the FY2025 annual result came in at -$0.74, down 2.89% from the prior year.
- Times Interest Earned was -$4.63 for Q1 2026 at Neurogene, up from -$27529.0 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$0.31 in Q4 2022 and bottomed at -$27529.0 in Q4 2025.
- A 5-year average of -$2495.5 and a median of -$37.03 in 2025 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2023 — Times Interest Earned sank 1605958.16% — and 2024, when it soared 99.99%.
- Neurogene's Times Interest Earned stood at -$0.31 in 2022, then sank by 1605958.16% to -$4911.0 in 2023, then soared by 99.89% to -$5.56 in 2024, then slumped by 495273.55% to -$27529.0 in 2025, then soared by 99.98% to -$4.63 in 2026.
- Business Quant data shows NGNE's Times Interest Earned at -$4.63 in Q1 2026, -$27529.0 in Q4 2025, and -$8.21 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Neurogene | 17.50 Mn | 17.50 Mn | - | -4.63 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.63 |
| Dec 31, 2025 | -27,529.00 |
| Sep 30, 2025 | -8.21 |
| Jun 30, 2025 | -17.39 |
| Mar 31, 2025 | -37.03 |
| Dec 31, 2024 | -5.56 |
| Sep 30, 2024 | -1.11 |
| Jun 30, 2024 | -1.49 |
| Mar 31, 2024 | -0.58 |
| Dec 31, 2023 | -4,911.00 |
| Sep 30, 2023 | -3,804.75 |
| Jun 30, 2023 | -839.73 |
| Mar 31, 2023 | -4,345.00 |
| Dec 31, 2022 | -0.31 |
| Sep 30, 2022 | -147.92 |
| Jun 30, 2022 | -220.43 |
| Mar 31, 2022 | -548.75 |
| Dec 31, 2021 | -0.60 |
| Sep 30, 2021 | -0.84 |
| Jun 30, 2021 | -0.58 |